Gregg Gilbert

In a report published Wednesday, Bank of America analyst Gregg Gilbert reiterated a Neutral rating on Sagent Pharmaceuticals (NASDAQ: SGNT), and raised the price target from $19.00 to $22.00. In the report, Bank of America noted, “Based on our review of two months of IMS sales data, we are raising...

In a report published Wednesday, Bank of America analyst Gregg Gilbert initiated coverage on Mallinckrodt plc (NYSE: MNK) with a Buy rating and $52.00 price target. In the report, Bank of America noted, “MNK markets brand and generic pain products, APIs and imaging agents. Sales, margins and EPS...